The scientist’s investigation covers issues in Internal medicine, Endocrinology, Hormone, Thyroid and Toxicity. His Internal medicine research includes elements of Offspring and Teratology. His study on Radioimmunoassay and Weanling is often connected to Ototoxicity as part of broader study in Endocrinology.
The concepts of his Thyroid study are interwoven with issues in Immunology, Triclosan, Endocrine disruptor and Xenobiotic. His Toxicity study incorporates themes from Inhalation and Audiology. His Corn oil research is multidisciplinary, relying on both Deltamethrin and Permethrin.
His main research concerns Endocrinology, Internal medicine, Toxicity, Pharmacology and Toxicology. As a part of the same scientific family, he mostly works in the field of Endocrinology, focusing on Offspring and, on occasion, Fetus. His research in Internal medicine intersects with topics in Teratology and Gestation.
As a part of the same scientific study, Kevin M. Crofton usually deals with the Toxicity, concentrating on Startle response and frequently concerns with Reflex and Moro reflex. Kevin M. Crofton has researched Pharmacology in several fields, including Potency, Cypermethrin, Pyrethroid, Deltamethrin and In vivo. His study in Toxicology is interdisciplinary in nature, drawing from both Hazard and Developmental neurotoxicity.
His scientific interests lie mostly in Adverse Outcome Pathway, Bioinformatics, Pharmacology, Developmental neurotoxicity and Risk analysis. His Bioinformatics study combines topics in areas such as Offspring, Neurotoxicity, Hormone, Thyroid and Epigenetics. His research in the fields of Triiodothyronine overlaps with other disciplines such as Thyroid neoplasm.
Kevin M. Crofton interconnects Esfenvalerate, Pyrethroid, Cypermethrin, In vivo and Deltamethrin in the investigation of issues within Pharmacology. His Developmental neurotoxicity study combines topics in areas such as Test, Toxicology, Neuroscience and Process. His Organification study is focused on Endocrinology and Internal medicine.
His primary areas of study are Adverse Outcome Pathway, Risk analysis, Hazard, In vitro and In vitro toxicology. His In vitro study integrates concerns from other disciplines, such as Endocrine disruptor, Endocrine system and High-throughput screening. His research investigates the link between Cytotoxicity and topics such as Bioassay that cross with problems in Pharmacology.
He works mostly in the field of Pharmacology, limiting it down to concerns involving Cell biology and, occasionally, In vivo. His study looks at the relationship between Developmental neurotoxicity and fields such as Matching, as well as how they intersect with chemical problems. His work deals with themes such as Biological target, Bioinformatics and Neurotoxicity, which intersect with Adverse outcomes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Developmental Exposure to Brominated Diphenyl Ethers Results in Thyroid Hormone Disruption
Tong Zhou;Michele M. Taylor;T. Michael J. Devito;Kevin M. Crofton.
Toxicological Sciences (2002)
Developmental Neurotoxicity of Pyrethroid Insecticides: Critical Review and Future Research Needs
Timothy J. Shafer;Douglas A. Meyer;Kevin M. Crofton;Kevin M. Crofton.
Environmental Health Perspectives (2005)
Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats
Tong Zhou;David G. Ross;Michael J. DeVito;Kevin M. Crofton.
Toxicological Sciences (2001)
Developmental Exposure to Polychlorinated Biphenyls (Aroclor 1254) Reduces Circulating Thyroid Hormone Concentrations and Causes Hearing Deficits in Rats
E. S. Goldey;L. S. Kehn;C. Lau;G. L. Rehnberg.
Toxicology and Applied Pharmacology (1995)
ToxCast Chemical Landscape: Paving the Road to 21st Century Toxicology
Ann M. Richard;Richard S. Judson;Keith A. Houck;Christopher M. Grulke.
Chemical Research in Toxicology (2016)
Risk assessment of combined exposure to multiple chemicals: A WHO/IPCS framework.
M E Bette Meek;Alan R Boobis;Kevin M Crofton;Gerhard Heinemeyer.
Regulatory Toxicology and Pharmacology (2011)
The effects of triclosan on puberty and thyroid hormones in male Wistar rats.
Leah M. Zorrilla;Emily K. Gibson;Susan C. Jeffay;Kevin M. Crofton.
Toxicological Sciences (2009)
Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols.
Tammy E. Stoker;Susan C. Laws;Kevin M. Crofton;Joan M. Hedge.
Toxicological Sciences (2004)
Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
Mark D. Miller;Kevin M. Crofton;Deborah C. Rice;R. Thomas Zoeller.
Environmental Health Perspectives (2009)
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
Knut Erik Tollefsen;Stefan Scholz;Mark T. Cronin;Stephen W. Edwards.
Regulatory Toxicology and Pharmacology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Environmental Protection Agency
National Institutes of Health
Research Triangle Park Foundation
University of Delaware
National Institutes of Health
University of Konstanz
University of California, Davis
Centre for Health Protection
National Institutes of Health
University of Zurich
University of California, Davis
University of California, Berkeley
University of Liège
University of Castilla-La Mancha
Yangzhou University
China University of Petroleum, Beijing
ETH Zurich
University of Washington
US Forest Service
Iuliu Hațieganu University of Medicine and Pharmacy
University of Groningen
University of Oxford
Flinders University
University of Amsterdam
Birkbeck, University of London